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Abstract
Background: the James Lind Alliance ( JLA) created an approach to elicit the views of those under-represented in research priority
exercises. Building on this, the JLA Dementia Priority Setting Partnership was set up as an independent and evidence-based project
to identify and prioritise unanswered questions (‘uncertainties’) about prevention, diagnosis, treatment and care relating to dementia.
Methods: a survey was widely disseminated to stakeholders with an interest in the needs of the older population. Thematic analysis
was used to identify themes from the large amount of questions collected from which research questions were developed using
985
Dementia priority setting partnership with the James Lind Alliance
 at U
niversity of Cam
bridge on O
ctober 29, 2015
http://ageing.oxfordjournals.org/
D
ow
nloaded from
 
PICO framework (Population, Intervention, Comparator, Outcome). Each question was checked against an extensive evidence base
of high-quality systematic reviews to verify whether they were true uncertainties.
Findings: one thousand ﬁve hundred and sixty-three questionnaires were received, from people with dementia, carers/relatives,
and health and care professionals; 85 uncertainties were identiﬁed from other sources. Questions were reﬁned and formatted it-
eratively into 146 unique uncertainties. An interim prioritisation process involving diverse organisations identiﬁed the top 25
ranked questions. At a ﬁnal face-to-face prioritisation workshop, 18 people representing the above constituencies arrived by con-
sensus at the top 10 priority questions. The impact of patient and public involvement on the priorities is discussed.
Interpretation: the long (146 questions) and top 10 lists of dementia research priorities provide a focus for researchers, funders
and commissioners. They highlight a need for more research into care for people with dementia and carers, and a need for high-
quality effectiveness trials in all aspects of dementia research.
Keywords: dementia, survey, priority setting, James Lind Alliance, public health, prevention, treatment, diagnosis, care, patient and
public involvement, carer, PPI, older people
Background
The number of people living with dementia in the UK and
worldwide is high, estimated at 800,000 people in the UK [1,
2] and 44 million people worldwide [3]. With an ageing popu-
lation, these ﬁgures are predicted to increase in the UK to over
a million people by 2021 [2] and worldwide to 135 million
by 2050 [4], despite recent estimates that future prevalence and
anticipated steep trajectory will be less profound [5].
The economic and societal impact of dementia places
demands on health, social care and community services as
well as family carers [1]. Recently, there has been acknowl-
edgement of the need for governments to address dementia
as a ‘public and health priority’ [6] and a call for national and
international coordination [2, 7–10]. To maximise resources,
there is a need to identify and prioritise unanswered questions
(‘uncertainties’) about prevention, diagnosis, treatment and
care relating to dementia from a wide societal perspective—
one that integrates the views of all stakeholders [11].
The research agenda is often set by the research commu-
nity or industry. However, this may not reﬂect the priorities
of people with dementia or their carers’ who live with the
impact of dementia in their daily lives. Patient and public
involvement (PPI) is increasingly being used to inform
research and practice to ensure that views and outcomes
relevant to service users and the public are included [12–16].
For dementia, inclusion of the views of people with de-
mentia, their carers’, clinicians, health and social care profes-
sionals and the wider public is needed.
The Alzheimer’s Society Public Health Advisory Committee,
with the University of Cambridge, initiated the Dementia
Priority Setting Partnership (PSP) with the James Lind Alliance
( JLA) to identify priorities for applied dementia research. The
JLA is a not-for-proﬁt organisation and is a part of the
National Institute for Health Research (NIHR) Evaluation,
Trials and Studies Coordinating Centre (NETSCC). JLA has
been developing methods to identify and prioritise uncertain-
ties since 2004 with a demonstrated impact on research calls
(http://www.lindalliance.org/DementiaPSP.asp) [17–22].
The aim of JLA PSPs is to involve patients/service users,
carers, and health and care professionals in identifying and
prioritising the top 10 ‘uncertainties’ (unanswered questions)
for research based on a rigorous, transparent and independ-
ent process. The objectives of the Dementia PSP were: (i) to
identify unanswered questions around the prevention, treat-
ment, diagnosis and care of dementia with the involvement
of all stakeholders; (ii) to identify a top 10 prioritised list of
uncertainties and (iii) to disseminate the results of the PSP to
researchers, research funders, commissioners, stakeholders
and the wider public.
Methods
The methods developed by the JLA for research priority
setting and their methods for involving patients, carers, clini-
cians and other stakeholders are open and transparent, and
the methodology followed was broadly that outlined in the
JLA guidebook [23].
While the JLA provides guidelines and a framework for the
methodology of PSPs, a pragmatic approach is taken so the
process can be adapted to meet the differing requirements of
PSP’s. The methodology described below in particular focuses
on those areas where the Dementia PSP may be differentiated
from other PSPs. In particular, the Dementia PSP was under-
pinned by a public health and population perspective. A the-
matic analysis approach was developed to manage, reﬁne and
develop research questions from the very large amount of col-
lected uncertainties. Moreover, each question was checked
against an extensive and complex evidence base of systematic
reviews, to verify whether they were true uncertainties.
The PSP process was conducted between April 2012 and
June 2013. Ethical approval was not required as completion
of the survey implied consent for submitted information to
be included; however, principles of ethical research were
followed such as conﬁdentiality.
Management and scope
The Dementia PSP was guided and chaired by an independ-
ent representative of the JLA and overseen by a steering
group (Supplementary data, Appendix, available in Age and
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Ageing online), which was actively engaged in the process.
The steering group deﬁned the scope of the project and
agreed on a protocol—both were published on the JLA
website at the start of the PSP process [24]. The scope
included prevention, treatment, diagnosis and care of people
with dementia; it did not include research on neurophysio-
logical mechanisms or causes of dementia.
Involvement of potential partner organisations
Potential partner organisations were identiﬁed through the
networks of the Alzheimer’s Society and the steering group,
ensuring representation from all stakeholders. Potential part-
ners were invited to an initial awareness meeting to explain
the project in April 2012. Those that signed up participated
in the process by publicising the project, disseminating the
survey, collecting completed surveys and prioritising ques-
tions for dementia research. Partner organisations and their
involvement are shown in Supplementary data S1, available
in Age and Ageing online.
Identifying uncertainties
A survey to collect uncertainties was designed using Survey
Monkey (www.surveymonkey.com) (Supplementary data S2,
available in Age and Ageing online). It included four questions,
relating to prevention, diagnosis, treatment and care of
dementia, with open text boxes and questions to collect
demographic data about respondents. This meant there were
no limits to the number, topic or format of questions that
respondents could submit. Initial piloting was conducted
among the Alzheimer’s Society general practitioner steering
group and Research Network volunteers, and issues raised
were addressed in the design of the survey.
The survey was available on the Alzheimer’s Society
website from April to July 2012 and distributed through
the Alzheimer’s Society monthly magazine, local ofﬁces,
Research Network volunteers, GP steering group, Facebook
and Twitter pages and social media launches. It was also distrib-
uted through the PSP partner organisations (Supplementary
data S1, available in Age and Ageing online), clinical, health and
social care professional bodies, and internal and external con-
tacts of the steering group (via meetings, conferences, emails,
newsletters, bulletins, web and social media). Efforts were
made in later dissemination rounds to increase responses from
groups that proved to be more challenging to access and were
initially under-represented (i.e. general practitioners, geriatri-
cians and old age psychiatrists, people with dementia, people
with no direct experience of dementia, and people from black
and minority ethnic groups). The survey could be completed
online or in paper format for reply to a Freepost address.
Uncertainties were also identiﬁed from existing research
recommendations from Cochrane systematic reviews and
NICE guidelines from 2005 onwards. Criteria for inclusion
were that a speciﬁc new research question within the PSP
scope was identiﬁed. Technical recommendations such as the
need for better-conducted, larger scale trials, or different ana-
lysis, trial design or measurement methods were not included.
Additionally, uncertainties from a previous small-scale,
in-house priority setting exercise conducted by the Alzheimer’s
Society’s Research Network of volunteers were included (http
://www.alzheimers.org.uk/site/scripts/documents_info.php?
documentID=1109), and the UK Database of Uncertainties
about the Effectiveness of Treatments was searched for pre-
viously registered uncertainties (http://www.library.nhs.uk/
duets/, January 2013, date last accessed).
Question management and analysis
The raw submissions received ranged from one question to
large tracts of questions and/or comments. Many of the
entries into free text boxes contained multiple questions, and
some single sentences contained multiple questions e.g.
‘Beneﬁt (or otherwise) of different foods, or exercise and
doing puzzles and mind exercises?’ Some submissions (or
parts of submissions) were just comments with no under-
lying question, e.g. ‘had scans 7 years ago’, and these were
excluded.
The ‘raw submissions’ were initially collated into an Excel
spreadsheet and managed using NVivo (v9, QSR International).
The data were categorised using themes identiﬁed in the raw
data (predeﬁned categories or ‘taxonomy’ were not used)
[23] using a thematic analysis approach. This meant that
there were no pre-conceptions about the question topics or
type of information received, which allowed us to observe
where questions were duplicated or similar questions were
asked. All data were managed by one researcher to enable
consistency in dealing with diverse but often interrelated
questions. Ambiguities were discussed and agreed with the
steering group.
The steering group reviewed the initial categorised ques-
tions and decided the following categories of question were
out of scope: underlying cause of dementia (e.g. ‘what is the
cause of dementia?’ or questions relating to underlying
neurophysiological causes), genetics/inheritance (e.g. ‘if my
parent had dementia am I likely to get it?’), media, stigma,
policy, funding and training. These questions were communi-
cated to the Alzheimer’s Society for information and use in
their programmes.
Questions that related to practical steps people could take
to prevent or reduce risk of dementia such as diet, exercise
or exposure to environmental toxins were included.
Through an extensive, iterative process, duplicate or
similar questions were combined and where necessary (and
possible) restructured according to the PICO (Population,
Intervention, Comparator, Outcome) format. Questions that
were not about interventions could not be fully converted
into PICO format, but population and outcome were
deﬁned where available; nor were some questions about risk
factors (e.g. ‘are viruses a risk factor for dementia?’) which
remained in original format.
Verifying uncertainties
Each question was checked against existing systematic
reviews to ensure it could not already be answered by up to
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date, high-quality, reliable evidence. Searching for systematic
reviews was initially limited to the Cochrane Library and the
databases of the York Centre for Reviews and Dissemination
(York CRD; www.crd.york.ac.uk/crdweb) which include the
Database of Abstracts of Reviews of Effects (DARE), NHS
Economic Evaluation Database (NHS-EED), and Health
Technology Assessment database, to meet the project time-
scale. These databases are sources of reliable systematic
reviews which meet set methodological standards. Keywords
used for the searches were ‘dementia’, ‘Alzheimer’s’, ‘cogni-
tion’ and ‘cognitive’ in the title and/or journal ﬁeld. This
identiﬁed 617 titles (March 2013) of which 185 were consid-
ered to be potentially relevant to the Dementia PSP ques-
tions and are shown in Supplementary data S3, available in
Age and Ageing online.
To check questions about dementia risk factors, which are
mainly addressed by reviews including prospective cohort
studies, other systematic reviews were identiﬁed from a con-
current dementia mapping project. MEDLINE, EMBASE,
CINAHL and PsycINFO were searched with the same key-
words using a systematic review ﬁlter. A further 41 relevant
reviews were identiﬁed. The combined total of 658 reviews
was cross-checked against the Dementia PSP questions.
Questions were considered to be uncertainties if there
was either: (i) no up-to-date, reliable systematic review, (ii)
up-to-date systematic reviews of research evidence showed
that there was not enough evidence available, (iii) the evi-
dence available was not of sufﬁciently high quality to make
robust conclusions about effectiveness or (iv) the available
evidence (of any type) reported in a systematic review was in-
conclusive.
The data available from systematic reviews were diverse.
Some systematic reviews included only randomised, con-
trolled trials (RCTs), but some reviews included a range of
study designs, such as a mixed methods approach or qualita-
tive data. Few reviews had sufﬁcient homogenous data to
report meta-analysis. Consideration was given to: (i) study
design of included studies in a systematic review, (ii) effect
size and estimated precision where available, (iii) quality and
consistency of the evidence and (iv) whether the review
answered all or part of a question.
The GRADE system (www.gradeworkinggroup.org) for
rating the quality of a body of evidence was used as a guide-
line wherever evidence was not clear. If a review only
answered part of a question, only the ‘uncertain’ parts of the
question were put through to the next stage of the process.
Final decisions on included questions were taken by the
steering group after consideration of the evidence and a clin-
ical or professional perspective.
Interim prioritisation
An interim prioritisation stage was conducted initially among
partner organisations to shorten the initial list of 146 ques-
tions to 25 questions to generate a manageable number for a
ﬁnal face-to-face prioritisation workshop. The questions
were listed in a random order. Not all partner organisations
took part, but care was taken to include a distribution of
representatives (Supplementary data S1, available in Age and
Ageing online). Each organisation was asked to rank their top
10 questions. They were free to generate their ranking
according to the most appropriate method for their organisa-
tion, but were asked to report the process and number of
people who participated [23]. Rankings from patients and
carers representatives and health and social care profes-
sionals were combined to provide an overall interim ranking.
The top 25 were presented to the ﬁnal prioritisation work-
shop in random order (Supplementary data S5, available in
Age and Ageing online).
Final prioritisation workshop
The aim of the workshop was to choose by consensus
between representatives of patients, carers, clinicians and
health and social care professionals, a ﬁnal top 10 uncertain-
ties from the list of 25 questions decided at interim prioritisa-
tion. This was held in London ( June 2013). The method
involved small-group sessions and ranking exercises based
on nominal group techniques [23, 25]. The process encour-
aged open discussion and involvement of all group members
guided by an independent JLA facilitator.
Results
The Dementia PSP received 1,563 completed surveys.
Respondents are shown in Table 1. Of these, the ethnic com-
position was White 78.6%, Black or Asian 2%, other 0.2%
and not stated 23.2%. As the survey covered four questions,
this generated 4,116 ‘raw submissions’. Additionally, 21 re-
search recommendations and 64 questions from the prior
Research Network priority exercise were added. Figure 1
shows the ﬂow of questions from the raw submissions to the
ﬁnal top 10 prioritised questions.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1.Dementia PSP survey respondents
Survey respondents % (n)
People with dementia 4.1 (64)
Family carer/relative 76.0 (1,188)
Health and care professional (+retired) 14.4 (224)
Carer 7.2 (16)
Geriatrician 2.9 (6)
GP 2.4 (5)
Nurse 27.0 (61)
Old age psychiatrist 6.3 (14)
Physiotherapist 1.9 (4)
Occupational Therapist 8.7 (20)
Social worker 3.4 (8)
Other 28.5 (64)
Not answered 11.7 (26)
No direct experience 1.4 (22)
Other 2.9 (46)
Not answered 1.2 (19)
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First round of combining and reformatting
The raw submissions were initially cleaned, combined and re-
formatted into a total of 1,106 questions (300 questions
about prevention, 325 about treatment, 258 about care and
223 about diagnosis).
Second round of combining and reformatting
After further combining and reformatting, including merging
similar questions across categories, 433 questions remained.
Many of the questions that were submitted had been asked
about by tens, or in some cases, hundreds of people.
Figure 1. Flow chart of Dementia PSP questions.
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Questions that only one or two people asked were excluded
(n = 149), after circulating to helpline staff at the Alzheimer’s
Society to identify any questions that were common queries.
Four questions were identiﬁed as regular queries and retained
(n = 4). Questions were organised across public health cat-
egories of primary prevention (n = 60), secondary and ter-
tiary prevention (combined, as there were only a few
questions about tertiary prevention) (n = 175), and questions
about diagnosis (n = 49).
At this stage, a total of 284 questions were checked
against systematic reviews. Twelve questions were considered
to be ‘known, answerable’ questions by the steering group
and were removed prior to the interim prioritisation stage.
Three questions were considered to be requests for in-
formation rather than research questions. Excluded ques-
tions were removed and passed to the Alzheimer’s Society
for information.
Third round of combining and reformatting
There were too many remaining (n = 272) questions at this
stage for interim prioritisation, based on the experience of
the JLAwith other PSPs (for consideration by groups repre-
senting patients, carers, and health and social care groups),
so further merging and combining were conducted to reach
150 questions. The questions were checked by the steering
group for clarity. Four questions were further merged, com-
bined or reworded.
When questions were combined, as much detail as pos-
sible was included into the combined question. (For example:
supplementary data S4, available in Age and Ageing online,
Question 100, ‘Can the onset of dementia be prevented or
delayed by dietary or nutritional factors?’—the question was
asked by many people about different speciﬁc foods, diets,
dietary patterns, components of diet and in different populations.
So these factors were all included in the question that went
forward for prioritisation).
Interim prioritisation
A list of 146 questions was sent to partner organisations in
April 2013. Sixty-one organisations participated representing
the views of people with dementia and their carers, and
health and social care practitioners (Supplementary data S1,
available in Age and Ageing online). The methods used by dif-
ferent organisations to rank the questions varied. Some orga-
nisations consulted with their members at meetings and
conferences, and some used the collective decision of a
group such as senior managers, but most were completed by
an individual representing the organisation.
Final prioritisation workshop
Eighteen participants took part in the workshop: six were
clinicians, ﬁve had a nursing and/or nursing management
and/or professional care background, ﬁve people were
family carers or former carers of people with dementia, and
two were people with dementia. The list of 25 questions was
sent out to participants before the meeting and participants
were asked to initially rank questions before attending the
workshop. Each participant was given the opportunity to
express their views on which questions they thought should be
prioritised and to hear other people’s perspectives. Participants
were free to debate and change their minds throughout the
process.
During the ﬁnal prioritisation workshop, participants con-
sidered some of the questions to be similar or related, and 7 of
the 25 questions were further merged together by workshop
participants. The research team observed that participants
were keen to include as many topics as possible within the top
10 priorities.
Final top 10 priorities
Table 2 shows the ﬁnal top 10 agreed priorities. It is notable
that nine of these ﬁnal questions were directly or indirectly
about care of people with dementia and their carers; one was
about diagnosis.
Impact of PPI
Of the 146 questions for interim prioritisation, most (n= 112)
were asked by both healthcare professionals and people with
dementia or their carers; 30 were asked only by people with
dementia or their carers, and only one (drug-related) question
was asked by healthcare professionals alone. No questions
were asked solely by people with dementia. The questions sub-
mitted by people with dementia were also asked by other
respondents. Of the 25 questions that went forward to the
ﬁnal prioritisation workshop, only one question was asked
only by people with dementia or their carers. At the ﬁnal
Table 2.Dementia PSP top 10 priorities
1. What are the most effective components of care that keep a person with
dementia as independent as they can be at all stages of the disease in all
care settings?
2. How can the best ways to care for people with dementia, including results
from research findings, be effectively disseminated and implemented into
care practice?
3. What is the impact of an early diagnosis of dementia and how can primary
care support a more effective route to diagnosis?
4. What non-pharmacological and/or pharmacological (drug) interventions
are most effective for managing challenging behaviour in people with
dementia?
5. What is the best way to care for people with dementia in a hospital setting
when they have acute healthcare needs?
6. What are the most effective ways to encourage people with dementia to eat,
drink and maintain nutritional intake?
7. What are the most effective ways of supporting carers of people with
dementia living at home?
8. What is the best way to care for people with advanced dementia (with or
without other illnesses) at the end of life?
9. When is the optimal time to move a person with dementia into a care home
setting and how can the standard of care be improved?
10. What are the most effective design features for producing dementia friendly
environments at both the housing and neighbourhood levels?
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prioritisation workshop that question was rated second in the
top 10 priorities.
Of the top 10 questions voted for at the interim prioritisa-
tion stage by people with dementia and carers, 6 were included
in the ﬁnal top 10 priorities. Of these, three were related ques-
tions about care which were merged into one broad question;
two were questions about non-pharmacological interventions
which were also merged; and one question was about early
diagnosis—ultimately yielding three questions in the ﬁnal top
10. Of the top 10 questions voted for at the interim prioritisa-
tion stage by healthcare professionals, 7 were included in the
top 10 priorities. Two questions about non-pharmacological
interventions were merged, while ultimately 6 of the questions
reached the ﬁnal top 10. Overall, both groups were fairly well
represented in the top 10 priorities.
Discussion
The Dementia PSP was conducted according to an extensive,
independent and transparent process to identify and priori-
tise questions for research. To our knowledge, these are the
ﬁrst priorities for dementia in which patients, carers, health
and care professionals, and the wider public have been
involved at all stages of the identiﬁcation and prioritisation
process. One report that used a limited list of 15 researcher-
deﬁned questions to consult with people with dementia,
carers and clinicians has been published [26].
While the broad areas of prevention, diagnosis, treatment
and care of people with dementia were well represented in
the ‘long list’ of 146 questions, only one question about pre-
vention of dementia was ranked in the top 25 questions and
none was voted into the top 10 priorities. The majority of
questions that were voted through the interim and ﬁnal
stages related to issues around care and support of people
with dementia and their carers. This may be a reﬂection that
many of the responding organisations are currently involved
in the daily care of people with dementia or their carers’, or
that these issues have not been adequately addressed in re-
search to date. Also, as those who took part in the prioritisa-
tion stages were representatives of people with dementia,
carers or established health and care professionals, there was
little representation from younger people who may have
more interest in longer term questions about the prevention
of dementia. However, the ‘long list’ of 146 questions was
identiﬁed through wide consultation with an extensive range
of stakeholders in dementia and as such are a reﬂection of
the concerns of people with dementia, their carers’, clinicians
and health and social care professionals.
All the questions will be available to others after being
entered onto the UK Database of Uncertainties about the
Effectiveness of Treatments (http://www.library.nhs.uk/duets)
if in a suitable PICO format, or published on the Alzheimer’s
Society website. The full ‘long list’ of 146 questions used for
prioritisation and the 25 top ranked questions considered at
the ﬁnal workshop are available as Supplementary data S4 and
S5, available in Age and Ageing online. The questions and the
details behind them have been submitted to NIHR and other
funders for consideration in their funding programmes, and to
date a number of NIHR funding calls have now been based
around the questions identiﬁed in this process.
Until more effective treatments are found for dementia,
the Dementia PSP priorities highlight that the issue of care
for people with dementia, and how to enable people to live
well with dementia, is also a research priority. Indeed, the G8
Dementia Summit and the ADI 2013 report have taken up
the theme that in global societies dementia research efforts
should include a focus on improving care and quality of life
for people with dementia as well as on the search for disease-
modifying therapies [4, 9].
Despite having scrutinised over 600 systematic reviews for
this Dementia PSP, most of the questions that were veriﬁed
against the evidence were still considered to be uncertainties.
This was because there was often no available systematic
review evidence, or where there was a systematic review, it
identiﬁed a lack of relevant studies to answer the question. For
some questions, there was evidence but the evidence available
was inconclusive or not of sufﬁciently high quality to make
robust conclusions. Responses to the identiﬁcation of these
uncertainties can include the belief that speciﬁc questions have
been addressed, but the question here is about whether that
evidence survives scrutiny on its strength. Thus, some ques-
tions may have been addressed by individual trials or study
designs that were not included in a systematic review.
However, individual trials may report differing results and
vary in study quality, so systematic review data provide a con-
sistent body of evidence that has also independently assessed
the quality and design of any included trials. Few systematic
reviews reported on the perspectives of people with dementia
themselves and there is a need for more work in this area.
Overall, the Dementia PSP has been an extensive and
wide-ranging process and has brought together a wide range
of stakeholders in dementia to prioritise questions for re-
search. PPI has provided a broader perspective to the re-
search agenda and in particular highlighted the need for
research into care and organisation of care and delivery of
services for people with dementia.
As far as possible, we have reported the process and
impact of public engagement according to the GRIPP check-
list for PPI involvement [27]. While the questions, interim
and ﬁnal prioritisation process may reﬂect concerns and
issues of importance to UK organisations and individuals,
many of the questions, particularly in the ‘long list’ of 146
questions, are likely to be applicable in the international co-
ordination of dementia research, as there were no country
restrictions on the systematic review evidence base.
Issues for consideration by researchers, research
funders and commissioners
The Dementia PSP priorities provide a focus for dementia
research across the prevention, treatment, diagnosis and care
of dementia. More attention needs to be put into well-
designed studies, including RCTs to demonstrate
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effectiveness that address the range of populations, interven-
tions and outcomes identiﬁed, including the perspectives and
outcomes that are of importance to people with dementia
and carers; such as quality of life, independence, manage-
ment of behaviour, effect on progression of disease, effect of
delaying moves to long-term care, effect on carers; and re-
search relevant to all sub-types of dementia and in popula-
tions at higher risk of dementia, such as those with a family
history or genetic risk factors for dementia.
Key points
• Incorporating PPI, including the views of people with de-
mentia, their carers’ and other stakeholders, in research is
important to ensure that issues of importance to them are
included in the research agenda.
• The Dementia Priority Setting Partnership involved people
with dementia, their carers’, clinicians and other health and
social care professionals in identifying, prioritising and dis-
seminating unanswered research questions relating to de-
mentia prevention, diagnosis, treatment and care.
• The top 10 priorities for dementia research identiﬁed by
the process are reported, and the full list of questions iden-
tiﬁed is also available.
• The Dementia PSP has highlighted issues around care, or-
ganisation of care and delivery of services for people with
dementia; a need for evidence from well-designed studies,
relevant to all sub-types of dementia, including in popula-
tions at higher risk of dementia and inclusion of the per-
spectives and outcomes of importance to people with
dementia themselves, and their carers’.
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Abstract
Background: previous studies have indicated a prevalence of dementia in older admissions of 42% in a single London
teaching hospital, and 21% in four Queensland hospitals. However, there is a lack of published data from any European
country on the prevalence of dementia across hospitals and between patient groups.
Objective: to determine the prevalence and associations of dementia in older patients admitted to acute hospitals in Ireland.
Methods: six hundred and six patients aged ≥70 years were recruited on admission to six hospitals in Cork County. Screening
consisted of Standardised Mini-Mental State Examination (SMMSE); patients with scores <27/30 had further assessment
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